StockGlow

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK)

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People's Republic of China and internationally.

483.80+0.01%Healthcare
Compare 6990.HK with
StockGlow Score
85
Bullish
BearishBullish
1 year ago+19.4%

The outlook

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. currently reads as bullish based on strong buy — 1.2 avg of 17 analysts, above its 50- & 200-day averages, 60% of the way from its 52-week low to high, avg target +17% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Analyst consensusStrong Buy — 1.2 avg of 17 analysts
Price trendAbove its 50- & 200-day averages
52-week range60% of the way from its 52-week low to high
Price targetAvg target +17% vs current price

Analyst price target

~12-month · 17 analysts
567.11average target+17.2% vs now
Now 483.80
Low 500.70High 666.57

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$115.64B
52-wk high
581.00
52-wk low
339.60
50-day avg
456.24
200-day avg
442.15
Trailing P/E
—

Similar stocks

9995.HKRemeGen Co., Ltd.$81.75+2.96%9926.HKAkeso, Inc.$93.95+0.80%9688.HKZai Lab Limited$14.30+0.78%9900.HKHong Kong Zcloud Technology Construction Limited$5.10-0.20%6979.HKZJLD Group Inc$7.97-3.16%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy